News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry

ByBy Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

September 26th 2022

Latest Updated Articles

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry
September 26th 2022

Trending on Psychiatric Times

Seltorexant as Adjunctive Therapy for MDD With Insomnia

Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health

Psychiatric Comorbidities in Adults With Congenital Heart Disease and the Need for Interdisciplinary Care

Podcast: Practical Insights Into the Evolving Treatment of Bipolar Disorder With David Dunner, MD, FACPsych

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder